Tribes Of Kendall Square: How To Parse Who's Who In Hotbed Of BiotechPlayCommonHealth08:06Jun 6, 2018
Primer: How To Speak Basic Biotech, From 'Transformative' To 'Valley Of Death'CommonHealthJun 4, 2018
Affording Miracles: As Biotech Victories In Gene Therapy Excite, Costs Spur Quest For New Ways To PayPlayCommonHealth08:57Jun 7, 2018
Next Era For Biotech: Designer Cells To Attack DiseasesA biotech CEO argues that the biggest news in the sector is not the creation of cures for specific diseases but rather of whole new types of treatments. CommonHealthJun 8, 2018
Could The 'BioBoom' Go Bust? How One MIT Professor Sees ItThe hope and promise of lifesaving medical treatments fuel biotech investor exuberance to the tune of billions of dollars per year in Massachusetts. MIT's Andrew Lo breaks down how a...PlayCommonHealth06:55Jun 8, 2018
Genetic Diseases Steal Too Many Kids' Futures. It Doesn't Have To Be This WayThe biotech industry needs to invest more in developing therapies for childhood diseases, ideally ones that can be given before symptoms arise, writes Geoff McDonough. CognoscentiJun 8, 2018
Number Of Women Leaders At Biotech Companies Lags — But Is ImprovingTwo leaders in biotech -- both women -- discuss how women in management benefit biotech companies, and what's being done to bring more women into executive office suites and board...PlayCommonHealth09:30Jun 7, 2018
One Of Biotech's Biggest Investors Says The Industry Must Be 'Unreasonable'Noubar Afeyan is one of biotech's most prolific investors. PlayCommonHealth06:56Jun 7, 2018
How Is The BioBoom Changing The Community — And Culture — Of Cambridge?We speak with Cambridge residents about how the biotech explosion is affecting the city, from swelling rents to -- arguably -- the further corporatization of Harvard Square.PlayRadio Boston28:32Jun 6, 2018
This Biotech Unicorn Hopes To Revolutionize Drug Making, But It Has Its SkepticsInvestors think Moderna Therapeutics holds a lot of promise -- a new technology that could revolutionize thousands of medicines.PlayCommonHealth05:26Jun 6, 2018
Women And People Of Color Are Underrepresented In Mass. BioTech. That Has To ChangeIt's time for the life sciences industry to expand access and opportunity to more women, people of color and people at all socioeconomic levels, writes David Lucchino, the chairman of...CognoscentiJun 6, 2018
How Kendall Square Became The Epicenter Of The Biotech WorldWe look at the history of the biotech industry in Boston.PlayRadio Boston18:30Jun 5, 2018
Mass. Life Sciences Center Anticipates $500 Million State InvestmentThe state Legislature is expected to pass a measure that would invest another $500 million in life science over the next five years. PlayRadio Boston16:30Jun 4, 2018
